nir fb lag16 (Addgene inc)
Structured Review

Nir Fb Lag16, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nir+fb+lag16/bio_rxiv__2025__10__27__684934-265-26-28?v=Addgene+inc
Average 93 stars, based on 1 article reviews
Images
1) Product Images from "Synthetic multicolor antigen-stabilizable nanobody platform for intersectional labelling and functional imaging"
Article Title: Synthetic multicolor antigen-stabilizable nanobody platform for intersectional labelling and functional imaging
Journal: bioRxiv
doi: 10.1101/2025.10.27.684934
Figure Legend Snippet: (a) Red fluorescence intensity of cells transfected with mCherry-Fb GFP , dTomato-Fb LAG16 without linkers, or dTomato-Fb LAG16 with –GGS-linkers and co-expressed with mEGFP (right column (+)) or mTagBFP2 (left column (−)). (b) Fluorescence images of HeLa cells co-expressing dTomato-Fb LAG16 with mTagBFP2 (negative control) or mEGFP (positive control). (c) Scheme of a VIS-Fb with a red FP (PDB ID: 1ZGO) inserted into LAG16 anti-GFP nanobody (PDB ID: 6LR7) bound to GFP-based biosensor GCaMP6m (PDB ID: 3WLD). Complementarity-determining regions (CDRs) are highlighted in violet. The position of dTomato insertion to the anti-GFP nanobody is indicated with a red arrow. (d) Upper, representative image of HeLa cells co-expressing GCaMP6s and dTomato-Fb LAG16 . Three regions of interest (ROIs) are indicated with white squares. Lower, changes in fluorescence intensity of the same cell co-expressing GCaMP6s (green) and dTomato-Fb LAG16 (red) in response to 5 μM ionomycin. Fluorescence changes for three ROIs are shown. (e) Upper, contrast of GCaMP6s only ( n=10 ) and GCaMP6s co-expressed with dTomato-Fb LAG16 ( n=11 ) after addition of 5 μM ionomycin. Lower, contrast of dTomato-Fb LAG16 ( n=11 ) for the data presented in the left graph. (f) Co-expression of dTomato-Fb LAG16 fused to RiboL1 tag and mEGFP in the soma of hippocampal neurons. In (a) fluorescence intensity was analyzed by flow cytometry using a 405 nm excitation laser and 450/50 nm emission filter for mTagBFP2; a 488 nm excitation laser and 525/50 nm emission filter for mEGFP; a 561 nm excitation laser and 610/20 nm emission filter for mCherry-Fb GFP and dTomato-Fb LAG16 . The maximal fluorescence of antigen-bound form for dTomato(GGS)-Fb LAG16 was assumed to be 100%. Data are presented as mean values ± s.d. for n = 3 transfection experiments. In (b, d, and f), the following filters were used: for imaging mEGFP and GCaMP6s 480/40 nm excitation and 535/40 nm emission; for imaging dTomato-Fb LAG16 and dTomato-Fb LAG16 -RiboL1 575/25 nm excitation and 615/30 nm emission. (b, d) Scale bar, 40 μm. (f) Scale bar, 20 μm.
Techniques Used: Fluorescence, Transfection, Expressing, Negative Control, Positive Control, Flow Cytometry, Imaging
Figure Legend Snippet: (a) Schematic of the experimental approach. An AAV vector driving dTomato-Fb LAG16 expression under the control of the hSyn promoter and the soma-targeting peptide RiboL1 was stereotactically injected into the somatosensory cortex of Thy1-GCaMP6f mice with preferential calcium indicator expression in a subset of excitatory pyramidal neurons. (b) Immunostaining validation. Left, example confocal fluorescence images showing GCaMP6f-(gray) and dTomato-expressing cells (red) in a cortical tissue section from an injected Thy1 -GCaMP6f mouse. Center, zoom-in of the indicated region. Scale bars, 250 μm (left) and 50 μm (center). Right, population analysis ( n=12 tissue sections from four mice). Data are presented as mean values ± SD. (c) In vivo validation. Left, example two-photon fluorescence image from a dual-color time-lapse recording showing GCaMP6f-(gray) and dTomato-expressing cells (red) in the somatosensory cortex of a behaving Thy1-GCaMP6f mouse. Recording depth (z) from the pial surface and seven somatic regions of interest (ROIs) is indicated. Center, fluorescence transients in the indicated ROIs are shown as ΔR/R (blue) for the combined channels. The simultaneously recorded mouse’s locomotor activity on a spherical treadmill is shown above the fluorescence traces. Scale bars, 50 μm (left), 50 mm/s and 200% (center). Right, zoom-ins of the two periods indicated in (c, center). (d) Schematic of the experimental approach. An AAV vector driving dTomato-Fb LAG16 expression under the control of the astrocyte enhancer 3xCore2(390m) was stereotactically injected into the somatosensory cortex of GFAP-GCaMP6f mice with preferential calcium indicator expression in astrocytes. (e) Immunostaining validation. Left, example confocal fluorescence images showing GCaMP6f-(gray) and dTomato-expressing cells (red) in a cortical tissue section from an injected GFAP -GCaMP6f mouse. Center, zoom-in of the indicated region. Scale bars, 250 μm (left) and 50 μm (center). Right, population analysis ( n=6 tissue sections from two mice). Data are presented as mean values ± SD. (f) In vivo validation. Left, example two-photon fluorescence image from a dual-color time-lapse recording showing GCaMP6f-(gray) and dTomato-expressing cells (red) in the somatosensory cortex of a behaving GFAP-GCaMP6f mouse. Recording depth (z) from the pial surface and seven somatic regions of interest (ROIs) is indicated. Center, fluorescence transients in the indicated ROIs are shown as ΔR/R (blue) for the combined channels. The simultaneously recorded mouse’s locomotor activity on a spherical treadmill is shown above the fluorescence traces. Scale bars, 50 μm (left), 50 mm/s and 200% (center). Right, zoom-ins of the two periods indicated in (f, center). (g) Schematic of the experimental approach. An AAV vector driving dTomato-Fb LAG16 expression under the control of the DLX2.0 enhancer was stereotactically injected into the somatosensory cortex of Viaat-GCaMP6f mice with calcium indicator expression in inhibitory interneurons. (h) Immunostaining validation. Left, example confocal fluorescence images showing GCaMP6f-(gray) and dTomato-expressing cells (red) in a cortical tissue section from an injected Viaat -GCaMP6f mouse. Center, zoom-in of the indicated region. Scale bars, 250 μm (left) and 50 μm (center). Right, population analysis ( n=6 tissue sections from two mice). Data are presented as mean values ± SD. (i) In vivo validation. Left, example two-photon fluorescence image from a dual-color time-lapse recording showing GCaMP6f-(gray) and dTomato-expressing cells (red) in the somatosensory cortex of a behaving Viaat-GCaMP6f mouse. Recording depth (z) from the pial surface and seven somatic regions of interest (ROIs) is indicated. Center, fluorescence transients in the indicated ROIs are shown as ΔR/R (blue) for the combined channels. The simultaneously recorded mouse’s locomotor activity on a spherical treadmill is shown above the fluorescence traces. Scale bars, 50 μm (left), 50 mm/s and 200% (center). (i) Zoom-ins of the two periods indicated in (i, center).
Techniques Used: Plasmid Preparation, Expressing, Control, Injection, Immunostaining, Biomarker Discovery, Fluorescence, In Vivo, Activity Assay